Recombinant Human Thrombopoietin Unknown Status Phase 4 Trials for Delayed Platelet Engraftment / Myeloablative / Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01379391Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT